Anne Thiebaut on Muck Rack

Anne Thiebaut

As seen in: Le Dauphiné libéré, Le Progrès, Le Journal de Saône-et-Loire, L'Alsace, Le Républicain Lorrain, L'Est Républicain, Le Bien Public, Vosges Matin, DNA (France)
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Anne

Contact Anne, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Letermovir for secondary prophylaxis of CMV infection and disease after allogeneic hematopoietic cell transplantation: Results from the French compassionate program

|
By Christine Robin, Paris-Est-Créteil, CHU Grenoble, Anne Thiebaut
| Biology of Blood and Marrow Transplantation Verified
Highligths • Letermovir was used for CMV secondary prophylaxis after allogeneic HCT in a compassionate program. • Letermovir was given from day 170 (median) for 118 days (median). • The drug was well tolerated. • Only 4/80 patients developed a CMV recurrence during letermovir prophylaxis. • Secondary prophylaxis of CMV recurrence is feasible with letermovir after allogeneic HCT. Abstract Letermovir potently inhibits the cytomegalovirus (CMV)-terminase complex.
Open in Who Shared Issue with article?
See all 1 licensed articles (21 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified